HAEMONETICS CORP (HAE)

HAEMONETICS CORP (HAE) public financial performance, SEC filing summary, and valuation metrics.

Financial highlights

Gross Profit: 202386000 usd (2025-12-27)
Operating Income: 67396000 usd (2025-12-27)
Contract Revenue: 138905000 usd (2025-12-27)
Net Income: 44740000 usd (2025-12-27)
Gross Profit: 194744000 usd (2025-09-27)
Operating Income: 58491000 usd (2025-09-27)
Contract Revenue: 125364000 usd (2025-09-27)
Net Income: 38684000 usd (2025-09-27)
Contract Revenue: 129897000 usd (2025-06-28)
Operating Income: 53872000 usd (2025-06-28)
Net Income: 34031000 usd (2025-06-28)
Gross Profit: 192244000 usd (2025-06-28)
Gross Profit: 748958000 usd (2025-03-29)
Contract Revenue: 535431000 usd (2025-03-29)
Operating Income: 221817000 usd (2025-03-29)
Net Income: 167679000 usd (2025-03-29)
Contract Revenue: 348542000 usd (2024-12-28)
Gross Profit: 193547000 usd (2024-12-28)
Operating Income: 70337000 usd (2024-12-28)
Net Income: 38373000 usd (2024-12-28)